Polypharmacology–foe or friend?
JU Peters - Journal of medicinal chemistry, 2013 - ACS Publications
Polypharmacology describes the activity of compounds at multiple targets. Current research
focuses on two aspects of polypharmacology:(1) unintended polypharmacology can lead to …
focuses on two aspects of polypharmacology:(1) unintended polypharmacology can lead to …
Thalidomide
ME Franks, GR Macpherson, WD Figg - The Lancet, 2004 - thelancet.com
Despite its history as a human teratogen, thalidomide is emerging as a treatment for cancer
and inflammatory diseases. Although the evolution of its clinical application could not have …
and inflammatory diseases. Although the evolution of its clinical application could not have …
Cutaneous sarcoidosis therapy updated
C Badgwell, T Rosen - Journal of the American Academy of Dermatology, 2007 - Elsevier
The widely accepted standard therapy for cutaneous sarcoidosis includes corticosteroids,
antimalarials, and methotrexate. However, a better understanding of the basic …
antimalarials, and methotrexate. However, a better understanding of the basic …
A mini-review on thalidomide: chemistry, mechanisms of action, therapeutic potential and anti-angiogenic properties in multiple myeloma
A Mercurio, G Adriani, A Catalano… - Current medicinal …, 2017 - ingentaconnect.com
Thalidomide is a drug with interesting therapeutic properties but also with severe side effects
which require a careful and monitored use. Potential immunomodulatory, antiinflammatory …
which require a careful and monitored use. Potential immunomodulatory, antiinflammatory …
Evidence-based therapy for cutaneous sarcoidosis
CB Doherty, T Rosen - Drugs, 2008 - Springer
Although healthcare providers have arrived at a relatively comfortable zone of accepted
clinical practice in the management of cutaneous sarcoidosis, virtually every treatment is …
clinical practice in the management of cutaneous sarcoidosis, virtually every treatment is …
Anti-angiogenic effect of silymarin on colon cancer LoVo cell line
SH Yang, JK Lin, WS Chen, JH Chiu - Journal of Surgical Research, 2003 - Elsevier
OBJECTIVE: This study was designed to evaluate the anti-angiogenic effect of silymarin
(SM) and its major pure component silibinin (SB), and also thalidomide (TH). MATERIALS …
(SM) and its major pure component silibinin (SB), and also thalidomide (TH). MATERIALS …
Neurological complications of sarcoidosis
BJ Stern - Current opinion in neurology, 2004 - journals.lww.com
Neurosarcoidosis can be 'staged'with the use of neurodiagnostic testing and diagnosed with
varying degrees of certainty. Treatment should be approached within the context of the …
varying degrees of certainty. Treatment should be approached within the context of the …
Small molecule intercalation with double stranded DNA: implications for normal gene regulation and for predicting the biological efficacy and genotoxicity of drugs and …
LB Hendry, VB Mahesh, ED Bransome Jr… - … Molecular Mechanisms of …, 2007 - Elsevier
The binding of small molecules to double stranded DNA including intercalation between
base pairs has been a topic of research for over 40 years. For the most part, however …
base pairs has been a topic of research for over 40 years. For the most part, however …
Thalidomide metabolism and hydrolysis: mechanisms and implications
ER Lepper, NF Smith, MC Cox… - Current drug …, 2006 - ingentaconnect.com
Despite its controversial past, thalidomide is currently under investigation for the treatment of
several disease types, ranging from inflammatory conditions to cancer. The mechanism of …
several disease types, ranging from inflammatory conditions to cancer. The mechanism of …
Thalidomide inhibits fibronectin production in TGF-β1-treated normal and keloid fibroblasts via inhibition of the p38/Smad3 pathway
CJ Liang, YH Yen, LY Hung, SH Wang, CM Pu… - Biochemical …, 2013 - Elsevier
Keloids are characterized by the vigorously continuous production of extracellular matrix
protein and aberrant cytokine activity in the dermis. There is a growing body of evidence that …
protein and aberrant cytokine activity in the dermis. There is a growing body of evidence that …